RTI Biologics and Athersys Collaboration in the Orthopedic Market
September 14th, 2010
No comments
RTI Biologics (Nasdaq: RTIX), a provider of orthopedic and other biologic implants, and Athersys (Nasdaq: ATHX), a regenerative medicine and cell therapy R&D; formed a collaboration Read more…
Categories: Orthopedic Collaboration, Stem Cell Technology
